Eugene Shenderov

16PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical mycologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 23, 2026
Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.

|May 05, 2026
NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer.

|Apr 29, 2026
Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target.

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.

|Feb 27, 2026
3D, multi-omic imaging reveals molecular biomarkers of the pre-metastatic niche in lung cancer.

John Michel, André Forjaz, Vasco Queiroga

|Jan 03, 2025
Nectin-4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study.

Ezra G Baraban, Evangelia Vlachou, Sunil Patel

Pageof 3

Frequent Collaborators

7 joint publications

Emmanuel S Antonarakis

5 joint publications

Tamara L Lotan

2 joint publications

Andrew Elliott

2 joint publications

Samuel R Denmeade